Chief Executive Officer @ (October 2011 - March 2017)
Consultant @ Cardeas Pharma (January 2011 - January 2013)
Consultant @ (January 2010 - January 2012)
Senior Director Product Development @ Aires Pharmaceuticals (January 2007 - January 2009)
Director Product Development @ (January 2001 - January 2007)
Consultant @ Bay Park Solutions (January 2006 - Present)
Mark Surber Education
University Of Illinois At Urbana - Champaign
Doctor of Philosophy (Genetics, Biochemistry, Microbiology)
California State University, Long Beach
Master of Science (Microbiology)
California State University, Long Beach
Bachelor of Science (Biochemistry, Microbiology)
Mark Surber Skills
Chemistry, Manufacturing, and Controls (CMC)
Inhalation
Entrepreneurship
Drug Discovery
Biotechnology
GLP
Infectious Diseases
Drug Development
Clinical Development
Clinical Trials
Clinical Research
Oncology
Formulation
Biochemistry
GMP
Technology Transfer
Genetics
Patents
FDA
Pharmaceutical Industry
Pharmacology
Life Sciences
Strategic Partnerships
Leadership
Business Development
Mergers and Acquisitions
Public Speaking
Strategy
Mark Surber Summary
Mark Surber, based in United States, is currently a CSO at Avalyn Pharma. Mark Surber brings experience from previous roles at Avalyn Pharma, Genoa Pharmaceuticals, Cardeas Pharma and Elevation Pharmaceuticals. Mark Surber holds a Doctor of Philosophy in Genetics, Biochemistry, Microbiology @ University Of Illinois At Urbana - Champaign. With a robust skill set that includes Chemistry, Manufacturing, and Controls (CMC), Inhalation, Entrepreneurship, Drug Discovery, Biotechnology and more. Mark Surber has 2 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Mark Surber?
Find contact details for 700 million professionals.